Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam combined with etomidate for anesthesia in elderly non-cardiac surgery patients
ChiCTR2400088496Phase 4Recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Aug 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam, etomidate and flumazenil (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Time for patient to follow instructions. Started Aug 2024; status: recruiting.
02
Drugs
remimazolametomidateflumazenil
Beyond the preview
Go deeper on ChiCTR2400088496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088496.